Literature DB >> 11165472

The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario.

H J Sutherland1, J Lacroix, J Knight, I L Andrulis, N F Boyd.   

Abstract

The Ontario Familial Breast Cancer Registry (OFBCR) is one of six international sites of the Cooperative Familial Registry for Breast Cancer Studies collecting family history, epidemiologic information, and blood samples from families (with various patterns of familial risk) for the purpose of studying the etiology of breast cancer. To invite 2361 female breast cancer patients residing in Ontario to take part in the Registry, a package was sent that included a Family History Questionnaire. Several variations of mailing and follow-up strategies were employed. Overall, the response rate was 67%. The best response (74%) was achieved by following up our introductory package of information with a postcard 10 days later and a telephone call several weeks thereafter. Given the design of the project, which involves a considerable commitment on the part of both patients and their family members, we are impressed by the positive response of these women.

Entities:  

Mesh:

Year:  2001        PMID: 11165472     DOI: 10.1016/s0895-4356(00)00263-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  6 in total

1.  A survey of the SWISS researchers on the impact of sibling privacy protections on pedigree recruitment.

Authors:  Bradford B Worrall; Donna T Chen; Robert D Brown; Thomas G Brott; James F Meschia
Journal:  Neuroepidemiology       Date:  2005-04-25       Impact factor: 3.282

2.  Psychometric properties of cancer survivors' unmet needs survey.

Authors:  H Sharon Campbell; Rob Sanson-Fisher; Donna Turner; Lynda Hayward; X Sunny Wang; Jill Taylor-Brown
Journal:  Support Care Cancer       Date:  2010-01-23       Impact factor: 3.603

3.  Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort.

Authors:  Kelly-Anne Phillips; Phyllis N Butow; Ailsa E Stewart; Jiun-Horng Chang; Prue C Weideman; Melanie A Price; Sue Anne McLachlan; Geoffrey J Lindeman; Michael J McKay; Michael L Friedlander; John L Hopper
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.

Authors:  Anita L Bane; Dushanthi Pinnaduwage; Sarah Colby; Michael Reedijk; Sean E Egan; Shelley B Bull; Frances P O'Malley; Irene L Andrulis
Journal:  Breast Cancer Res Treat       Date:  2008-06-18       Impact factor: 4.872

5.  When research seems like clinical care: a qualitative study of the communication of individual cancer genetic research results.

Authors:  Fiona A Miller; Mita Giacomini; Catherine Ahern; Jason S Robert; Sonya de Laat
Journal:  BMC Med Ethics       Date:  2008-02-22       Impact factor: 2.652

6.  Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis.

Authors:  Jane C Figueiredo; Julia A Knight; Stewart Cho; Sevtap Savas; U Venus Onay; Laurent Briollais; Pamela J Goodwin; John R McLaughlin; Irene L Andrulis; Hilmi Ozcelik
Journal:  BMC Cancer       Date:  2007-06-14       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.